Investigation in silico the interaction of oxazolinyl derivatives of [17(20)E]-21-norpregnene with androgen receptor
Biomedical Chemistry: Research and Methods · 2018
DOI: 10.18097/bmcrm00008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chemistry: Research and Methods, 2018. Verfasst von K.A. Shcherbakov und 5 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
The ability of novel oxazolinyl derivatives of pregna-5,17(20)-diene to interact with the androgen receptor (AR) was investigated using molecular modelling methods. Six new derivatives differed in oxazolinyl radicals in 17 position were used. It was shown that all compounds were able to docked in the ligand-binding domain of AR only when the AR helix-12 was removed. It is suggested that these compounds have antagonistic properties. Results of docking and simulation of molecular dynamics with estimation of binding energy allow to predict that two compounds can be effective AR antagonists.
Zitieren
APA
Shcherbakov, K., Shcherbinin, D., Kostin, V., Zolottsev, V., Misharin, A., & Veselovsky, A. (2018). Investigation in silico the interaction of oxazolinyl derivatives of [17(20)E]-21-norpregnene with androgen receptor. Biomedical Chemistry: Research and Methods. https://doi.org/10.18097/bmcrm00008
Vancouver
Shcherbakov K, Shcherbinin D, Kostin V, Zolottsev V, Misharin A, Veselovsky A. Investigation in silico the interaction of oxazolinyl derivatives of [17(20)E]-21-norpregnene with androgen receptor. Biomedical Chemistry: Research and Methods. 2018. doi:10.18097/bmcrm00008
BibTeX
@article{Shcherbakov2018,
author = {Shcherbakov, K.A. and Shcherbinin, D.S. and Kostin, V.A. and Zolottsev, V.A. and Misharin, A.Yu. and Veselovsky, A.V.},
title = {Investigation in silico the interaction of oxazolinyl derivatives of [17(20)E]-21-norpregnene with androgen receptor},
journal = {Biomedical Chemistry: Research and Methods},
year = {2018},
doi = {10.18097/bmcrm00008}
}
EUVIMED